Rosie O’Donnell Credits Gradual GLP-1 Dosing for Weight Loss Success

O’Donnell revealed on the “Bleep!” podcast that she started her journey with a 2.5mg dose, gradually increasing to 5mg in her second year and 7.5mg in her third. By avoiding a rapid ramp-up, she bypassed the nausea, vomiting, and appetite-related issues frequently cited by the Cleveland Clinic as standard reactions to the drug. For O’Donnell, the medication served as a tool to quiet what she describes as “food noise,” a lifelong struggle that once led her to hunt for her children's hidden Halloween candy in the middle of the night.

Following a 65-pound weight loss, O’Donnell also opted for a facelift to address loose skin, specifically targeting “marionette lines” that she felt misrepresented her actual mood. She chose to be transparent about both her medical weight loss and her cosmetic surgery, arguing that honesty is a form of empowerment. Her experience mirrors that of other public figures, such as Andy Cohen, who recently shared his own success with “microdosing” GLP-1s to address health risks like arterial plaque, emphasizing that the drugs act as a bridge toward building more sustainable, disciplined lifestyle habits.